New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.
Individuals with two HNPCC-associated cancers a including synchronous and metachronous colorectal cancers or associated extracolonic cancers Individuals with colorectal cancer and a first-degree ...
Colon cancer is on the rise in younger people, which is why testing guidelines recommend testing starting at 45 for those at average risk. To stop colon cancer, it’s important to know when and how to ...
Fecal occult blood testing, a patient-administered test that is much less expensive than a colonoscopy, is a valid option for early detection of colon cancer, according to a report in the Canadian ...
This article is brought to you by Blue Cross and Blue Shield of Louisiana. Colon cancer has become more predominant across the nation in recent years, with the American Cancer Society estimating that ...
WBRE Wilkes-Barre on MSN
Unexpected colon cancer screening test show up at your door? This may be why
According to Cologuard, made by Wisconsin-based Exact Sciences, there are three primary reasons why you may receive a testing kit in the mail without ordering it yourself: your doctor or health care ...
(Reuters Health) - People may be more likely to get colorectal cancer screenings when doctors let them choose what type of test to have, a U.S. study suggests. Researchers focused on two widely used ...
Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...
As moms, we're constantly vigilant about our family's health, but there's a concerning trend that deserves our attention: colon cancer rates are surging among younger adults ( that's you and me, ...
Occasional constipation is common, but doctors warn that constipation lasting for months may signal colon cancer, especially if bowel habits change. Experts say persistent constipation with symptoms ...
Data support routine use of circulating tumor DNA testing in management of stage III colon cancer patients Tumor fraction analysis provides further insights for patient management in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback